Literature DB >> 20878140

[Electroconvulsive therapy. Indications, procedure and treatment results].

H W Folkerts1.   

Abstract

Electroconvulsive therapy (ECT) is one of the most effective forms of treatment for severe and persistent psychiatric disorders. ECT is used for a broad spectrum of diseases; however, it has proven particularly helpful in the treatment of therapy-resistant depressive episodes. In addition it has also been successfully used in the treatment of other disorders, such as acute mania and acute psychotic states. Basically ECT should be considered in all cases of severe psychiatric disorder in which an adequate psychopharmacological and/or psychotherapeutic treatment strategy has failed or when the side-effects of medications have proven unbearable. As with other forms of psychiatric treatment ECT is not always used in the same manner and in different institutions in the same way and there are also differences in opinions between clinicians and researchers on various aspects of ECT. In this article the up-to-date standards for effective ECT treatment are outlined and discussed in the light of the current knowledge.

Entities:  

Mesh:

Year:  2011        PMID: 20878140     DOI: 10.1007/s00115-010-3130-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

Review 1.  Anesthesia for electroconvulsive therapy: a review.

Authors:  J W Folk; C H Kellner; M D Beale; J M Conroy; T A Duc
Journal:  J ECT       Date:  2000-06       Impact factor: 3.635

2.  [For and against: broader indication of electroconvulsive therapy].

Authors:  Francesca Regen; Malek Bajbouj; Ion Anghelescu; Here Folkerts
Journal:  Psychiatr Prax       Date:  2005-11

3.  A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT.

Authors:  Colleen K Loo; Kirby Sainsbury; Patrick Sheehan; Bill Lyndon
Journal:  Int J Neuropsychopharmacol       Date:  2008-08-28       Impact factor: 5.176

4.  The STAR*D trial: revealing the need for better treatments.

Authors:  Thomas R Insel; Philip S Wang
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

Review 5.  [Electroconvulsive therapy of depressive disorders].

Authors:  H Folkerts
Journal:  Ther Umsch       Date:  2000-02

Review 6.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

7.  Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy.

Authors:  P Sienaert; K Vansteelandt; K Demyttenaere; J Peuskens
Journal:  J Affect Disord       Date:  2008-12-10       Impact factor: 4.839

8.  Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.

Authors:  Christian Geretsegger; Marius Nickel; Berthold Judendorfer; Erika Rochowanski; Erich Novak; Wolfgang Aichhorn
Journal:  J ECT       Date:  2007-12       Impact factor: 3.635

9.  Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

Authors:  Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand
Journal:  Brain Stimul       Date:  2008-04       Impact factor: 8.955

  9 in total
  3 in total

Review 1.  [Anesthesia for electroconvulsive therapy].

Authors:  U Grundmann; S O Schneider
Journal:  Anaesthesist       Date:  2013-04       Impact factor: 1.041

2.  ["Even electricity cannot work wonders!". Neglected achievements by German psychiatrists around 1880 in the treatment of depressions and psychoses].

Authors:  H Steinberg
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

Review 3.  [Treatment against the patient's will exemplified by electroconvulsive therapy : Clinical, legal and ethical aspects].

Authors:  D Zilles; M Koller; I Methfessel; S Trost; A Simon
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.